AAAAAA

   
Results: 1-10 |
Results: 10

Authors: VANSCHAICK EA ZUIDEVELD KP TUKKER HE LANGEMEIJER MWE IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., METABOLIC AND CARDIOVASCULAR EFFECTS OF THE ADENOSINE A(1) RECEPTOR AGONIST N-6-(P-SULFOPHENYL)ADENOSINE IN DIABETIC ZUCKER RATS - INFLUENCE OF THE DISEASE ON THE SELECTIVITY OF ACTION, The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 21-30

Authors: VANSCHAICK EA TUKKER HE ROELEN HCPF IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., SELECTIVITY OF ACTION OF 8-ALKYLAMINO ANALOGS OF N-6-CYCLOPENTYLADENOSINE IN-VIVO - HEMODYNAMIC VERSUS ANTI-LIPOLYTIC RESPONSES IN RATS, British Journal of Pharmacology, 124(3), 1998, pp. 607-618

Authors: VANSCHAICK EA DEGREEF HJMM IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., PHYSIOLOGICAL INDIRECT EFFECT MODELING OF THE ANTILIPOLYTIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS, Journal of pharmacokinetics and biopharmaceutics, 25(6), 1997, pp. 673-694

Authors: VANSCHAICK EA KULKARNI C KUNZEL JKVD MATHOT RAA CRISTALLI G IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., TIME-COURSE OF ACTION OF 3 ADENOSINE A(1) RECEPTOR AGONISTS WITH DIFFERING LIPOPHILICITY IN RATS - COMPARISON OF PHARMACOKINETIC, HEMODYNAMIC AND EEG EFFECTS, Naunyn-Schmiedeberg's archives of pharmacology, 356(6), 1997, pp. 827-837

Authors: VANSCHAICK EA MATHOT RAA GUBBENSSTIBBE JM LANGEMEIJER MWE ROELEN HCPF IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., 8-ALKYLAMINO-SUBSTITUTED ANALOGS OF N-6-CYCLOPENTYLADENOSINE ARE PARTIAL AGONISTS FOR THE CARDIOVASCULAR ADENOSINE A(1) RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 800-808

Authors: VANDERGRAAF PH VANSCHAICK EA MATHOT RAA IJZERMAN AP DANHOF M
Citation: Ph. Vandergraaf et al., MECHANISM-BASED PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE EFFECTS OF N-6-CYCLOPENTYLADENOSINE ANALOGS ON HEART-RATE IN RAT - ESTIMATION OF IN-VIVO OPERATIONAL AFFINITY AND EFFICACY AT ADENOSINE A(1) RECEPTORS, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 809-816

Authors: VANSCHAICK EA DEGREEF HJMM LANGEMEIJER MWE SHEEHAN MJ IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF THE ANTI-LIPOLYTIC AND ANTI-KETOTIC EFFECTS OF THE ADENOSINE A(1)-RECEPTOR AGONIST N-6-(P-SULPHOPHENYL)ADENOSINE IN RATS, British Journal of Pharmacology, 122(3), 1997, pp. 525-533

Authors: VANSCHAICK EA JACOBSON KA KIM HO IJZERMAN AP DANHOF M
Citation: Ea. Vanschaick et al., HEMODYNAMIC-EFFECTS AND HISTAMINE-RELEASE ELICITED BY THE SELECTIVE ADENOSINE A(3) RECEPTOR AGONIST 2-CL-IB-MECA IN CONSCIOUS RATS, European journal of pharmacology, 308(3), 1996, pp. 311-314

Authors: MATHOT RAA VANSCHAICK EA LANGEMEIJER MWE SOUDIJN W BREIMER DD IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIP OF THE CARDIOVASCULAR EFFECTS OF ADENOSINE A(1) RECEPTOR AGONIST N-6-CYCLOPENTYLADENOSINE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 616-624

Authors: MATHOT RAA APPEL S VANSCHAICK EA SOUDIJN W IJZERMAN AP DANHOF M
Citation: Raa. Mathot et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE ADENOSINE A(1) AGONIST N-6-CYCLOPENTYLADENOSINE AND THE A(1) ANTAGONIST 8-CYCLOPENTYLTHEOPHYLLINE AND ITS APPLICATION IN A PHARMACOKINETIC STUDY IN RATS, Journal of chromatography. Biomedical applications, 620(1), 1993, pp. 113-120
Risultati: 1-10 |